Stay updated on Efficacy Safety of Sintilimab IBI310 in EBV Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Efficacy Safety of Sintilimab IBI310 in EBV Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Efficacy Safety of Sintilimab IBI310 in EBV Gastric Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page footer now displays revision v3.8.0 instead of v3.7.2.
    Difference
    0.1%
    Check dated 2026-11-01T16:22:43.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    A site-wide banner announces an NIH terminology transition, saying agencies are using “Super Intelligence” in place of “Artificial Intelligence.”
    Difference
    0.8%
    Check dated 2026-10-25T19:13:56.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-18T22:37:25.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer now identifies the site as revision v3.7.1 instead of v3.7.0.
    Difference
    0.1%
    Check dated 2026-10-11T22:34:43.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    A new Revision: v3.7.0 is added to the study's history and Revision: v3.6.6 is removed, reflecting an update to the record's version history.
    Difference
    0.2%
    Check dated 2026-09-20T22:27:22.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    A new revision version v3.6.6 was added to the study record history. The previous revision v3.6.5 was removed from the visible history.
    Difference
    0.1%
    Check dated 2026-08-30T22:37:15.000Z thumbnail image

Stay in the know with updates to Efficacy Safety of Sintilimab IBI310 in EBV Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Efficacy Safety of Sintilimab IBI310 in EBV Gastric Cancer Clinical Trial page.